Gain Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Gain Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Gain Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $8K, unchanged year-over-year.
  • Gain Therapeutics, Inc. annual Depreciation for 2023 was $34.9K, a 31% increase from 2022.
  • Gain Therapeutics, Inc. annual Depreciation for 2022 was $26.6K, a 72% increase from 2021.
  • Gain Therapeutics, Inc. annual Depreciation for 2021 was $15.5K, a 61.4% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $34.9K +$8.24K +31% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $26.6K +$11.1K +72% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $15.5K +$5.89K +61.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $9.59K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.